Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 7/20 | 0.56 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.51 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.51 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.51 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 3/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4035878 | 0.81 | SLC6A4 (0.56) | PYCR1HTR2ASLC6A4KCNH2 | |
| SCHEMBL680436 | 0.81 | TAAR1 (0.60) | TAAR1KMT2AGPR84 | |
| SCHEMBL8169154 | 0.79 | CHRNA7 (0.53) | TAAR1CHRNB2CHRNA7CHRNA4PYCR1 | |
| SCHEMBL11452260 | 0.79 | PYCR1 (0.51) | PYCR1HTR2ASLC6A4KCNH2KMT2A | |
| SCHEMBL13840628 | 0.78 | TAAR1 (0.56) | TAAR1HTR2ASLC6A4KCNH2 | |
| SCHEMBL3857244 | 0.78 | CHRNA7 (0.51) | TAAR1CHRNB2CHRNA7CHRNA4HTR2A | |
| SCHEMBL27519718 | 0.76 | PYCR1 (0.45) | PYCR1HTR2ASLC6A4KCNH2KMT2A | |
| SCHEMBL6684805 | 0.76 | PYCR1 (0.45) | PYCR1HTR2ASLC6A4KCNH2KMT2A | |
| SCHEMBL8163718 | 0.75 | HTR2A (0.63) | TAAR1CHRNB2CHRNA7CHRNA4PYCR1 | |
| SCHEMBL27499357 | 0.75 | HTR2A (0.54) | TAAR1HTR2ASLC6A4KCNH2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170044104-A1 | NEW PESTICIDAL COMPOUNDS AND USES | BAYER ANIMAL HEALTH GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044104-A1 | NEW PESTICIDAL COMPOUNDS AND USES | ACHE, DDT, DNPH1 | TAAR1 2141/4885CHRNB2 1908/4885CHRNA7 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.